Medicina
Fachbereich
Gustave Roussy Cancer Campus
Villejuif, FranciaPublikationen in Zusammenarbeit mit Forschern von Gustave Roussy Cancer Campus (9)
2023
2018
-
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries
British Journal of Haematology, Vol. 181, Núm. 3, pp. 350-359
2016
-
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry
Human Molecular Genetics, Vol. 25, Núm. 6, pp. 1203-1214
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296
-
Genome-wide association study identifies multiple loci associated with bladder cancer risk
Human Molecular Genetics, Vol. 23, Núm. 5
-
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, Vol. 32, Núm. 8, pp. 760-767
2010
-
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nature Genetics, Vol. 42, Núm. 11, pp. 978-984
2002
-
Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project
Public Health Nutrition, Vol. 5, Núm. 6 B, pp. 1287-1296